Rallybio Corporation (RLYB) Tops Q3 EPS by 9c

Rallybio Corporation (NASDAQ: RLYB) reported Q3 EPS of ($0.26), $0.09 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $299 thousand versus the consensus estimate of $75 thousand.

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.

You May Also Be Interested In

• Canaccord Starts BillionToOne Inc (BLLN) at Buy
• Increasing unusual put option volume: IHI HBAN DBX FOXA EYPT CARR FEZ DT NVS ITB HWM TRIP
• MiniMed Group (MMED) PT Raised to $28 at BofA Securities